are placed using a combination of US and a transperineal electromagnetic-tracked MR/US fusion device (Invivo, Gainesville, FL). 48 hours' post-ablation, the patient is imaged, fig 1, followed by re-imaging and MR/US fusion guided biopsy (FBx) at 3 months. All patient demographics, clinical variables, and complications were recorded.
INTRODUCTION AND OBJECTIVES:
The Real-time Virtual Sonography (RVS) system allows image-fusion of real-time live US with pre-operative contrast-enhanced CT/MRI. Both real-time US and fusedimage of CT are real-timely displayed in parallel in US-machine. The objectives are to assess the feasibility and safety of a pilot study for offie RVS-guided renal mass biopsy (RMB).
METHODS: Pre-operative: After 8 hours of fasting, the patient is placed in prone position in outpatient facility and monitored. US/CT registration: The DICOM data of a previous CT scan or MRI is loaded into the RVC system. The image is rotate to be at the same orientation of the patient. The kidney of interest and the plane with a reference point that a shows a good window to puncture the renal mass is selected.The kidney of interest is then US-scanned and the images are compared with the CT scan. When the images match to each other the plane with the reference point is fused with pre-operative contrast CT scan using the RVS system. The kidney is scanned and the best location to target the renal mass is selected. Co-axial needle technique: A 17G hollow needle is connected to a needle-guide under 21-degree inclination and attached to the US probe. Under local anesthesia, a 17G hollow-needle, is first placed along the planned puncturing dotted-line toward the renal mass up to the Gerota 0 s fascia. Biopsy: A 18G biopsy-gun is inserted through the coaxial-outersheath, advanced along the planned puncturing dotted-line upto the tumor and is fired to obtain the biopsy-tissue from the tumor. Usually two to three cores are taken, all through the hollow needle.
RESULTS: From April to June of 2014, 13 patients underwent RMB. Only single-use of local anesthesia was required in all cases.
Co-axial needle technique facilitated (i) visualization of the biopsyneedle in live US, (ii) multiple-sampling through it, and (iii) decreasing the seeding risk of malignant cells. RVS system facilitated targeting the contrast-enhanced lesion, as it improved visualization of important anatomical landmarks. Intra-operatively accompanied pathology-team was important to determine the adequacy of tissue-sampling. Biopsy histology was concordant with surgical specimen in 7 of 10 patients undergoing surgery. Additionally, 2 patients with histology of oncocytoma chose active surveillance. There were no complications.
CONCLUSIONS: Outpatient RMB performed by urologist is safe and promising. This was achieved using local anesthesia, co-axial needle technique, and intra-operative co-operation with pathologyteam, and introduction of real-time image-fusion technology of live US with contrast CT/MRI. lymphangiography has been used to detect lymphatic channels under fluorescent light and to aid in the excision of affected lymph nodes. We describe our novel technique of robotic inguinal lymphadenectomy with near infrared fluorescence imaging using ICG to facilitate lymph node identification during robotic groin dissection for penile cancer.
METHODS: Using a high definition recording system and iMovie software with narrative and annotative editing, we created a video of our novel technique for robotic inguinal lymphadenectomy with near infrared fluorescence imaging using the Surgical Intuitive Da Vinci Xi robot. Robotic ports are placed in a V configuration at the tip of the femoral triangle after development of the working space by blunt finger dissection. Intradermal ICG is injected at the penile stump or base (0.5 ml of 2 mg/kg concentration in normal saline) and the lymphatic channels and nodes are visualized with near infrared fluorescence imaging in the robotic console approximately 15 minutes after injection. The surgical template established via the open approach is then replicated.
RESULTS: A total of 8 groin dissections have been completed using this technique with a mean lymph node yield of 8 per groin (range 5-16 lymph nodes). With a follow up ranging from 3-16 months, there have been no post-operative infections, lymphatic leaks, wound breakdown, or necrosis. All pathologically proven nodes were identified intra-operatively with ICG.
CONCLUSIONS: Our novel technique of robotic inguinal lymphadenectomy with fluorescence lymphangiography using ICG facilitates identification of lymph channels and nodes. It is reproducible, safe, and helps ensure complete excision of both superficial and deep lymph nodes during groin dissection for penile cancer. This technique may dramatically decrease the morbidity compared to the open technique without compromising oncologic efficacy. Further prospective studies are required to assess the long term results of this procedure.
Source of Funding: none

V4-05 IMPACT OF THE 20 G ALL-SEEING NEEDLE AND 4.8 FR MICRO PCNL WITH THE HIGH DEFINITION IMAGE GUIDE (HDIG) SYSTEM
INTRODUCTION AND OBJECTIVES: PCNL is the first-line therapy for large and complex renal calculi. To perform PCNL safely and effectively, the most important step is the formation of a nephrostomy tract and tract dilatation. Furthermore, as fine a nephroscope as possible is required for micro PCNL. In this clinical study, renal puncture using 20 G all-seeing needle and 4.8 Fr micro PCNL were performed for large renal stone using a micro-optic disposable scope.
METHODS: The f0.65 mm scope with the High Definition Image Guide (HDIG) system reported in previous WCE held in Taiwan (2014) was adopted. The scope consists of an integrated light lead and the micro fiber optic including a f0.5 mm precise object lens and optical glass fiber, where real-time HD images can be seen through the digital image processing device. The scope can be set inside a 20 G puncture needle or 4.8 Fr metal sheath which can simultaneously include the micro-optic scope, 0.018 inch guidewire and 200 mm laser fiber. These devices are developed as part of a collaborative research with Takei Medical & Optical Co. Ltd. (Tokyo, Japan) and Sumita Optical Glass Inc. (Saitama, Japan) funded by Utsukushima Next-Generation Medical Industry Agglomeration Project between 2012 and 2014. After evaluating safety, optical quality and operation performance in an animal study, the clinical study authorized by the ethical committee of Okayama University Hospital was carried out from June 2013. The procedures of micro PCNL are as follows; ultrasound-guided renal puncture using 20 G all-seeing needle, removal of the scope followed by insertion of 0.018 inch guidewire, dilatation by metal introducer, insertion of 4.8 Fr metal sheath into renal calyx, insertion of the HDIG scope into the sheath, complete fragmentation of calculi by Ho-YAG LASER without removal of the fragments.
RESULTS: A 68-year old male with renal calculi 21 mm in diameter in left lower calyx once underwent the puncture and the micro PCNL. After the operation, spontaneous discharge of fragmented calculi through lower urinary tract was observed and abdominal X-ray on POD 21 showed no fragment in his left kidney. No adverse event was occurred except slight elevation of serum creatinine during only a week postoperatively.
CONCLUSIONS: The micro-optic disposable scope with the HDIG system is extremely useful for safer puncture and finer PCNL. We are now planning to adopt it to percutaneous procedure for urothelial carcinoma in upper urinary tract.
Source of Funding: None
V4-06 THE DEVELOPMENT OF A WEB-BASED VIDEO PLATFORM FOR TEACHING THE ROBOTIC SIMPLE PROSTATECTOMY
Nicholas Kavoussi*, Igor Sorokin, Jeffrey Gahan, Dallas, TX INTRODUCTION AND OBJECTIVES: The vast majority of resident surgical teaching in the United Sates is performed in the operating room. Instructional feedback on technique is nearly exclusively given at the time of surgery. However, this current model poses problems in the modern era due to pressures for increased surgical throughput and resident duty hour restrictions. We have developed a web-based, interactive platform that uses novel video technology (compatible with most media devices) to enhance surgical teaching. We have taken the first step in implementing the training platform by assessing the platform's usability to teach the robotic simple prostatectomy and to ensure trainee participation using a validated, industry standard questionnaire.
METHODS: All urology surgical trainees at our institution were given access to a web-based surgical training platform. This platform allows trainees to easily upload video segments of surgeries they performed for expert (attending physician) review. The experts are alerted through email and are prompted to give text based comments as feedback. The feedback is embedded within the video and is time congruent to the task being performed. The trainees are alerted to the reviewer's comments and are prompted to review the video containing expert feedback. To evaluate the platform as a teaching tool, the trainees were given access to the platform, asked to watch the steps of a robotic simple prostatectomy, leave comments, and then complete the System Usability Survey (SUS). This is a 10 question, survey to assess the perceived usability of web-based products. The SUS is an industry standard and has been proven and validated by a large database of web-based platforms to effectively differentiate usable and unusable products.
RESULTS: Out of the 21 trainees at our institution, all accessed the website during the study period. A total of 17/21 (81%) used the platform and completed the SUS. The average SUS score was 85 for our platform, which correlates to a usability in the top 10% of technology based systems. The SUS score of 85 also correlates with continued usage and increased likelihood that users would recommend the platform to other trainees.
CONCLUSIONS: Our web-based surgical training platform has shown very favorable usability, which makes it likely to be utilized by residents as a teaching tool. The platform is well equipped for teaching robotic simple prostatectomy or other relatively low volume surgical procedures. Future studies are aimed at tracking and quantifying resident platform utilization and correlating this to resident surgical skill progression. METHODS: We performed CEUS immediately pre-and postablation, and during follow up of the patients who underwent HIFU for localized prostate cancer using either Ablatherm â or Sonacare â . After conventional trans-rectal US (TRUS) examination (GE Healthcare, Chicago, IL), a 1.5 cc bolus of the ultrasound contrast agent LUMASON â (sulfur hexafluoride lipid-type A microspheres) was injected intravenously. Two minutes cine images of the regions of interest were obtained and time intensity curves (TIC) were concurrently generated.
RESULTS: From Dec/2015 to Sep/2016, 12 consecutive patients that underwent HIFU were evaluated by CEUS. Median (range) age, PSA and prostate volume were 64 yr (55-83), 6.25 ng/ml (2.8-19.6) and 29 cc (18-51), respectively. Hemi/subtotal/whole-gland HIFU were performed in 9/1/2 patients, respectively. In a median follow up of 5.3 months (2.2-10), the PSA decreased 88% (35-98). In one patient the PSA did not decrease and biopsy confirmed local recurrence. CEUS findings: 1) On pre-HIFU, the cancer area demonstrated higher peak intensity (PI) and shorter time to peak than the non-cancer area. 2) The PI was at about 25 sec and the wash out continued up to the end of the 2 min recording. 3) The TIC provided quantification of enhancement of treated and untreated prostate, therefore decreasing subjectiveness. 4) CEUS provided real time visualization of ablated area with clear and sharp margins. 5) CEUS provided confirmation that the targeted region of interest was precisely treated as planned. 6) The treated area could be visualized immediately after ablation and the ablation defect persisted on follow up (Figure) .
CONCLUSIONS: CEUS provides a real time feedback with visualization and quantification of the actual treated and untreated areas on intraoperative and follow up evaluation of patients undergoing HIFU ablation of the prostate. Vol. 197, No. 4S, Supplement, Saturday, May 13, 2017 THE JOURNAL OF UROLOGY â e377
